To further investigate whether the effects of E6 on HNSCC are really dependent on NF-κB and Akt signaling, we utilized PDTC and MK-2206, which are specific inhibitors of NF-κB and Akt signaling, respectively. The gene discussed is AKT1; the disease is head and neck squamous cell carcinoma.